641
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Sequential development of peripheral t-cell lymphoma post immunochemotherapy of diffuse large B cell lymphoma

, , &
Pages 201-202 | Received 21 Nov 2016, Accepted 08 Feb 2017, Published online: 24 Mar 2017

Figures & data

Figure 1. DLBCL in the root of tongue. (A) Histopathology of tongue showed diffuse infiltration of large B-cell lymphocytes (H&E,×400). (B) Immunohistochemical stain with anti-CD20 antibody (×200). (C) Anti-CD79α antibody (×200). (D) Anti-CD3 antibody (×200).

Figure 1. DLBCL in the root of tongue. (A) Histopathology of tongue showed diffuse infiltration of large B-cell lymphocytes (H&E,×400). (B) Immunohistochemical stain with anti-CD20 antibody (×200). (C) Anti-CD79α antibody (×200). (D) Anti-CD3 antibody (×200).

Figure 2. PTCL in inguinal lymph node. (A) Lymph node biopsy showed small-to-medium-sized T-cell lymphocytes in the setting of arborizing endothelial venules (H&E,×400). (B) Immunohistochemical stain with anti-CD2 antibody (×200). (C) Anti-CD3 antibody (×200). (D) Anti-CD20 antibody (×200).

Figure 2. PTCL in inguinal lymph node. (A) Lymph node biopsy showed small-to-medium-sized T-cell lymphocytes in the setting of arborizing endothelial venules (H&E,×400). (B) Immunohistochemical stain with anti-CD2 antibody (×200). (C) Anti-CD3 antibody (×200). (D) Anti-CD20 antibody (×200).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.